{"entity":{"type":"insider","cik":"0001572000","url":"/insider/0001572000","json_url":"/insider/0001572000.json","name":"Lubner David Charles","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":11,"first":"2014-02-11","last":"2026-08-07","span_basis":"filed_date"},"name_variants":[{"name":"Lubner David Charles","source":"filing","n_filings":11,"first_seen":"2014-02-11","last_seen":"2026-08-07"}],"transactions":[{"id":6185385,"accession":"0001470831-26-000796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000796","line_url":"/filing/0001470831-26-000796#line-1","is_derivative":false,"issuer_cik":"0001572000","issuer_name":"Braveheart Bio, Inc.","issuer_ticker":"BRVE","issuer_name_source":null,"issuer_url":"/issuer/0001572000","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55555.0,"shares_display":"55,555","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":999990.0,"total_display":"999,990.00","total_whole":"999,990","shares_owned_after":55555.0,"shares_owned_after_display":"55,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-07","scope":"insider"},{"id":5943224,"accession":"0001193125-26-017002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-017002","line_url":"/filing/0001193125-26-017002#line-2","is_derivative":false,"issuer_cik":"0001572000","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001572000","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":21659.0,"shares_owned_after_display":"21,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider"},{"id":6718588,"accession":"0001104659-22-122395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-122395","line_url":"/filing/0001104659-22-122395#line-1","is_derivative":false,"issuer_cik":"0001572000","issuer_name":"POINT Biopharma Global Inc.","issuer_ticker":"PNT","issuer_name_source":null,"issuer_url":"/issuer/0001572000","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3600.0,"shares_display":"3,600","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":24660.0,"total_display":"24,660.00","total_whole":"24,660","shares_owned_after":3600.0,"shares_owned_after_display":"3,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-28","scope":"insider"},{"id":8301063,"accession":"0001209191-15-066319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-066319","line_url":"/filing/0001209191-15-066319#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":42.92,"price_display":"42.92","price_state":"stated","total_value":407740.0,"total_display":"407,740.00","total_whole":"407,740","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8375020,"accession":"0001209191-15-060993","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-060993","line_url":"/filing/0001209191-15-060993#line-3","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":48.92,"price_display":"48.92","price_state":"stated","total_value":366900.0,"total_display":"366,900.00","total_whole":"366,900","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-14","filed_date":"2015-07-15","scope":"insider"},{"id":8494919,"accession":"0001209191-15-053888","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-053888","line_url":"/filing/0001209191-15-053888#line-3","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":41.67,"price_display":"41.67","price_state":"stated","total_value":312525.0,"total_display":"312,525.00","total_whole":"312,525","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider"},{"id":8494909,"accession":"0001209191-15-053888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-053888","line_url":"/filing/0001209191-15-053888#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":41.29,"price_display":"41.29","price_state":"stated","total_value":412900.0,"total_display":"412,900.00","total_whole":"412,900","shares_owned_after":69270.0,"shares_owned_after_display":"69,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-12","filed_date":"2015-06-16","scope":"insider"},{"id":8719929,"accession":"0001209191-15-043845","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-043845","line_url":"/filing/0001209191-15-043845","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":39.28,"price_display":"39.28","price_state":"stated","total_value":589200.0,"total_display":"589,200.00","total_whole":"589,200","shares_owned_after":79270.0,"shares_owned_after_display":"79,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-18","scope":"insider","n_lines":2},{"id":7014853,"accession":"0001209191-14-042351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-042351","line_url":"/filing/0001209191-14-042351#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13530.0,"shares_display":"13,530","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":169260.3,"total_display":"169,260.30","total_whole":"169,260","shares_owned_after":78463.0,"shares_owned_after_display":"78,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-17","filed_date":"2014-06-18","scope":"insider"},{"id":7033168,"accession":"0001209191-14-018837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-018837","line_url":"/filing/0001209191-14-018837#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4510.0,"shares_display":"4,510","price_per_share":13.65,"price_display":"13.65","price_state":"stated","total_value":61561.5,"total_display":"61,561.50","total_whole":"61,562","shares_owned_after":91993.0,"shares_owned_after_display":"91,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-10","scope":"insider"},{"id":6908680,"accession":"0001209191-14-010470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-010470","line_url":"/filing/0001209191-14-010470#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4506.0,"shares_display":"4,506","price_per_share":13.92,"price_display":"13.92","price_state":"stated","total_value":62723.52,"total_display":"62,723.52","total_whole":"62,724","shares_owned_after":96503.0,"shares_owned_after_display":"96,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-13","scope":"insider"},{"id":7068156,"accession":"0001209191-14-009097","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-009097","line_url":"/filing/0001209191-14-009097#line-4","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001572000","owner_name":"Lubner David Charles","owner_display_name":"Lubner David Charles","owner_url":"/insider/0001572000","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9928.0,"shares_display":"9,928","price_per_share":14.22,"price_display":"14.22","price_state":"stated","total_value":141176.16,"total_display":"141,176.16","total_whole":"141,176","shares_owned_after":101009.0,"shares_owned_after_display":"101,009","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-02-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002131524","name":"Braveheart Bio, Inc.","url":"/issuer/0002131524","role":"Director","n_filings":1,"first_seen":"2026-08-07","last_seen":"2026-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001786205","name":"Arcellx, Inc.","url":"/issuer/0001786205","role":"Director","n_filings":1,"first_seen":"2026-01-20","last_seen":"2026-01-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001811764","name":"POINT Biopharma Global Inc.","url":"/issuer/0001811764","role":"Director","n_filings":1,"first_seen":"2022-11-28","last_seen":"2022-11-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Officer (SVP and CFO)","n_filings":8,"first_seen":"2014-02-11","last_seen":"2015-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001572000","retrieved_at":"2026-08-24T01:21:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}